Search Results - "Shepard, H. Michael"

Refine Results
  1. 1

    Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer by Whatcott, Clifford J, Diep, Caroline H, Jiang, Ping, Watanabe, Aprill, LoBello, Janine, Sima, Chao, Hostetter, Galen, Shepard, H Michael, Von Hoff, Daniel D, Han, Haiyong

    Published in Clinical cancer research (01-08-2015)
    “…Pancreatic ductal adenocarcinoma (PDAC) is characterized by high levels of fibrosis, termed desmoplasia, which is thought to hamper the efficacy of…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Breaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer Therapy by Shepard, H Michael

    Published in Frontiers in oncology (28-08-2015)
    “…Hyaluronan (HA) has many functions in the extracellular milieu of normal and diseased tissues. Disease-associated HA accumulation has been shown to predict a…”
    Get full text
    Journal Article
  5. 5

    Tumor-associated hyaluronan limits efficacy of monoclonal antibody therapy by Singha, Netai C, Nekoroski, Tara, Zhao, Chunmei, Symons, Rebecca, Jiang, Ping, Frost, Gregory I, Huang, Zhongdong, Shepard, H Michael

    Published in Molecular cancer therapeutics (01-02-2015)
    “…Despite tremendous progress in cancer immunotherapy for solid tumors, clinical success of monoclonal antibody (mAb) therapy is often limited by poorly…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models by Thompson, Curtis B, Shepard, H Michael, O'Connor, Patrick M, Kadhim, Salam, Jiang, Ping, Osgood, Ryan J, Bookbinder, Louis H, Li, Xiaoming, Sugarman, Barry J, Connor, Robert J, Nadjsombati, Sinisa, Frost, Gregory I

    Published in Molecular cancer therapeutics (01-11-2010)
    “…Hyaluronan (HA) is a glycosaminoglycan polymer that often accumulates in malignancy. Megadalton complexes of HA with proteoglycans create a hydrated connective…”
    Get full text
    Journal Article
  8. 8

    Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family by Shepard, H Michael, Brdlik, Cathleen M, Schreiber, Hans

    Published in The Journal of clinical investigation (01-11-2008)
    “…The human EGFR (HER) family is essential for communication between many epithelial cancer cell types and the tumor microenvironment. Therapeutics targeting the…”
    Get full text
    Journal Article
  9. 9

    Therapeutic targeting of hyaluronan in the tumor stroma by Kultti, Anne, Li, Xiaoming, Jiang, Ping, Thompson, Curtis B, Frost, Gregory I, Shepard, H Michael

    Published in Cancers (06-09-2012)
    “…The tumor stroma, consisting of non-malignant cells and the extracellular matrix, undergoes significant quantitative and qualitative changes throughout…”
    Get full text
    Journal Article Book Review
  10. 10
  11. 11

    Trastuzumab: dreams, desperation and hope by Shepard, H. Michael

    Published in Nature reviews. Cancer (01-05-2024)
    “…The story of trastuzumab begins with Axel Ullrich’s dedication to the concept that receptor tyrosine kinases must be the key to many human diseases. It…”
    Get full text
    Journal Article
  12. 12

    KIAA1199 expression and hyaluronan degradation colocalize in multiple sclerosis lesions by Marella, Mathieu, Jadin, Laurence, Keller, Gilbert A, Sugarman, Barry J, Frost, Gregory I, Shepard, H Michael

    Published in Glycobiology (Oxford) (01-12-2018)
    “…Abstract Modification of hyaluronan (HA) accumulation has been shown to play a key role in regulating inflammatory processes linked to the progression of…”
    Get full text
    Journal Article
  13. 13

    Characterization of a Novel Recombinant Hyaluronan Binding Protein for Tissue Hyaluronan Detection by Jadin, Laurence, Huang, Lei, Wei, Ge, Zhao, Qiping, Gelb, Arnold B., Frost, Gregory I., Jiang, Ping, Shepard, H. Michael

    “…Tumor necrosis factor-Stimulated Gene 6 protein (TSG-6) is a hyaluronan (HA)-binding glycoprotein containing an HA-binding Link module. Because of its…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Biomarker-Driven Drug Discovery in Cancer—Trastuzumab Development: 2019 Lasker-DeBakey Clinical Medical Research Award by Shepard, H. Michael

    “…In this Viewpoint, 2019 Lasker-DeBakey Clinical Medical Research Award winner H. Michael Shepard discusses development of trastuzumab, the first fully…”
    Get full text
    Journal Article
  17. 17

    The Team that Just Wouldn’t Quit and a New Paradigm in Cancer Drug Discovery by Shepard, H. Michael

    Published in Cell (19-09-2019)
    “…Receiving the Lasker award for Clinical Medical Research is a staggering event. Perhaps equally staggering is the fact that as many as 2 million women…”
    Get full text
    Journal Article
  18. 18

    Developments in therapy with monoclonal antibodies and related proteins by Shepard, H Michael, Phillips, Gail Lewis, Thanos, Christopher D, Feldmann, Marc

    Published in Clinical medicine (London, England) (01-06-2017)
    “…Monoclonal antibody therapeutics have been approved for over 30 targets and diseases, most commonly cancer. Antibodies have become the new backbone of the…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockade by Gompels, Luke L, Malik, Nasser M, Madden, Leigh, Jin, Pei, Feldmann, Marc, Shepard, H Michael, Paleolog, Ewa M

    Published in Arthritis research & therapy (01-01-2011)
    “…Rheumatoid arthritis (RA) is a chronic disease associated with inflammation and destruction of bone and cartilage. Although inhibition of TNFα is widely used…”
    Get full text
    Journal Article